Together, let’s Be Lunacious and rewrite the story of global health.
Join the LunaVax Mission
Join us in closing the vaccine gap across Nigeria and Africa. We're tackling malaria, tuberculosis (TB), pneumococcal disease, Haemophilus influenzae type b (Hib), HPV, rotavirus, yellow fever, polio, measles, hepatitis B, and DTP (diphtheria, tetanus, and pertussis). Through local innovation and delivery, we welcome scientists, public health leaders, advocates, and bold thinkers to be part of the mission. Explore how you can get involved.
Vaccine Patches: Painless, Powerful, Needle-Free
We're is introducing microneedle patches (MAPs), a painless, needle-free way to deliver vaccines in underserved areas. Our pilot focuses on measles, with plans to expand into malaria and other high-burden diseases. We’re also tracking MAPs for TB and HPV as part of our long-term pipeline. Learn more about microneedle patches from Gavi.
Partner with LunaVax to Build Africa’s Vaccine Access Ecosystem
LunaVax is building Africa’s Vaccine Access Ecosystem—layer by layer, partner by partner. From microneedle patches and biometrics to vials, mobile delivery, data tools, and local manufacturing, we’re rethinking the system behind vaccine access. We work with clinics, funders, and innovators to make immunization smarter, faster, and more equitable. Explore how to become a LunaVax partner.
Innovative Vaccine Delivery: Smart Vans & Drones
LunaVax brings vaccines directly to hard-to-reach communities through mobile clinics and drone delivery. Our vans provide on-the-spot immunization, while drones navigate difficult terrain to ensure fast, temperature-stable supply. Together, they expand access where it's needed most. Learn more about our delivery systems.
Inside the Vial: Our Science
We harness cutting-edge science to develop vial-based vaccines using mRNA, self-amplifying RNA (saRNA), protein subunit, viral vector, and DNA platforms. These safe, scalable technologies address Africa’s most urgent vaccine-preventable diseases and support Nigeria’s immunization goals for measles, TB, yellow fever, and rotavirus, where injectable formats remain essential. Explore our vaccine platforms.
Pilot Launch: Join the MAP Vaccine Study in Lagos & Abuja
We’re inviting clinics, pharmacies, and outreach providers to pilot microneedle patches for measles immunization in Nigeria—powered by LunaVax and backed by Harvard Medical School. Help us shape the future of vaccine delivery. Learn more about the pilot and how to get involved.
Piloting microneedle vaccine patches and mobile vans in Nigeria — starting with measles. Learn how we’re reimagining vaccine delivery in hard-to-reach areas.—read the full article.
Sign up to volunteer — and read the full post to help shape the future of vaccines.
Stay updated on our latest breakthroughs! Explore our latest insights on vaccine innovation, partnerships, and funding.